This Diagnosing Health Care episode dives into the key business operations and legal considerations for reshoring active pharmaceutical ingredient (or “API”) and finished drug product manufacturing to the United States. The...more
10/13/2020
/ 3D Printing ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Foreign Manufacturers ,
Generic Drugs ,
Offshoring ,
Pharmaceutical Industry ,
Prescription Drugs ,
Reshoring ,
Supply Chain ,
Tax Credits